WE ARE NO LONGER ACCEPTING TOPAMAX CASES
Topamax, active ingredient topiramate, is used to treat one of two primary conditions that patient is suffering from: migraines and seizures (convulsions). Approved by the U.S. Food & Drug Administration in March of 2014 for prevention of the former in adolescents ages 12 to 17 (and originally approved in 2004 for treatment of adults), Topamax is not without serious risks.
Several lawsuits have been filed against Topamax’s manufacturer, Janssen Pharmaceuticals, Inc., on the basis that Janssen knew of potential risks associated with taking Topamax, but failed to disclose those risks to consumers.
One of the most serious risks associated with taking Topamax is the risk of birth defects when taken by pregnant women. Specifically, the risk of an infant being born with cleft palate or cleft palate is especially high when the infant’s mother took Topamax during pregnancy.
Other risks of Topamax include:
- Eye problems;
- Metabolic acidosis; and
- Suicidal thoughts or actions.
Why Janssen Pharmaceuticals May Be Held Liable for Harm You Suffered
If you were not told of the risks of taking Topamax prior to using it, and suffered adverse harm as a result or gave birth to a child with a birth defect, Janssen Pharmaceuticals, Inc. may be held liable. This is because Janssen violated its duty to conduct adequate testing on the drug, and to disclose the results of those tests—and the risks of Topamax—to the consumer.
How an Attorney Can Help
If taking Topamax has harmed you, you are not alone. At Napoli Shkolnik, PLLC, we have represented dangerous drug victims all across the country, and know what it takes to win a suit against a major pharmaceutical company. To learn more about your right to damages, schedule a consultation with our experienced pharmaceutical litigation team today.